- In some people, SARS-CoV-2 infection can cause inflammation of the lungs and pneumonia. A large randomized clinical trial has found that the steroid dexamethasone can reduce the risk of death in…
- Coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The numbers of people affected by COVID-19 will repeatedly fluctuate over the coming…
- SARS-CoV-2 infects cells and forces them to produce copies of this virus. Small errors, or mutations, in the production of copies of SARS-CoV-2 occur from time to time. These mutations result in a…
- There are many potential medicines in development for the prevention and treatment of COVID-19. One group of potential therapies is called monoclonal antibodies.
- Scientists at Regeneron Pharmaceuticals have developed two antibodies that attack different parts of SARS-CoV-2. The combination of antibodies is called Regen-CoV.
- Regen-CoV is the brand name of a combination of two antibodies that attack SARS-CoV-2. The antibodies are as follows:
- Regen-CoV is the brand name of a combination of two antibodies that attack SARS-CoV-2. The antibodies are as follows:
- AT-527 is a nucleoside analogue that is being developed as a potential treatment for COVID-19. The drug is taken orally. This drug is an analogue of a naturally occurring substance called guanosine.…
- Adenoviruses are a large family of viruses that can cause a range of illness in people and animals. In people, these viruses can cause relatively mild illness such as colds and pink eye or more…
- Clinical trials of the Janssen COVID-19 vaccine (in some parts of the world this is called the Johnson & Johnson COVID-19 vaccine) have found that it is generally safe.